Accueil   Diary - News   All news Nosopharm to present new first-inclass clinical candidate

Nosopharm to present new first-inclass clinical candidate

ASM Microbe 2018: Nosopharm to present new first-inclass clinical candidate to tackle Enterobacteriaceae infections

 

Nosopharm, a company dedicated to the research and development of new anti-infective drugs, announces that it has been selected to present its first-in-class clinical candidate, NOSO-502, at today’s New Agents Discovery Summary Session at ASM Microbe 2018 (June 7-11, Atlanta, GA, USA).




Read the press release